Pellerin, L.; Carrié, L.; Dufau, C.; Nieto, L.; Ségui, B.; Levade, T.; Riond, J.; Andrieu-Abadie, N.
Lipid metabolic Reprogramming: Role in Melanoma Progression and Therapeutic Perspectives. Cancers 2020, 12, 3147.
https://doi.org/10.3390/cancers12113147
AMA Style
Pellerin L, Carrié L, Dufau C, Nieto L, Ségui B, Levade T, Riond J, Andrieu-Abadie N.
Lipid metabolic Reprogramming: Role in Melanoma Progression and Therapeutic Perspectives. Cancers. 2020; 12(11):3147.
https://doi.org/10.3390/cancers12113147
Chicago/Turabian Style
Pellerin, Laurence, Lorry Carrié, Carine Dufau, Laurence Nieto, Bruno Ségui, Thierry Levade, Joëlle Riond, and Nathalie Andrieu-Abadie.
2020. "Lipid metabolic Reprogramming: Role in Melanoma Progression and Therapeutic Perspectives" Cancers 12, no. 11: 3147.
https://doi.org/10.3390/cancers12113147
APA Style
Pellerin, L., Carrié, L., Dufau, C., Nieto, L., Ségui, B., Levade, T., Riond, J., & Andrieu-Abadie, N.
(2020). Lipid metabolic Reprogramming: Role in Melanoma Progression and Therapeutic Perspectives. Cancers, 12(11), 3147.
https://doi.org/10.3390/cancers12113147